Acorda Therapeutics Inc 's

Name: Acorda Therapeutics Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ACORQ Sales vs. its Competitors Q1 2024

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

<< ACORQ Stock Performance Comparisons

Acorda Therapeutics Inc 's Comment on Competition and Industry Peers

The pharmaceutical market for neurological conditions such as Parkinson's disease and multiple sclerosis is competitive, with numerous companies possessing greater resources and experience. Inbrija competes with therapies approved for intermittent use in Parkinson's disease, including Apokyn. Companies developing pulmonary delivery products that may compete with Inbrija include Alexza Pharmaceuticals, Inc., Pulmatrix, Inc., Vectura Group plc, PureIMS B.V., Allergan, Inc., GlaxoSmithKline plc, MannKind Corporation, and Novartis AG. Impel Neuropharma is developing intranasally delivered levodopa therapies that could also compete with Inbrija. Ampyra has faced competition from generic versions since late 2018, leading to a significant decline in sales, with further decreases expected as additional generic manufacturers enter the market.

<< See the full list of ACORQ competitors

*Market share is calculated based on total revenue.

ACORQ's Stock Performance relative to its Competitors

Publicly Traded Peers of Acorda Therapeutics Inc

Sources: Acorda Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Acorda Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.